Luteinized Unruptured Follicle Syndrome: When Ovulation Tests Lie

In a normal cycle a follicle grows, ruptures, and releases the egg. The remaining shell then becomes the corpus luteum and produces progesterone.

In luteinized unruptured follicle syndrome, the second half of that sequence happens without the first. The follicle luteinizes and starts producing progesterone, but it never ruptures. The egg stays inside.

The consequence is specific and complete: no egg enters the fallopian tube, so fertilization cannot occur in that cycle, no matter how well timed intercourse or insemination is.

What makes LUF unusual among ovulation disorders is that it is invisible to every routine test:

• The LH surge happens normally, so ovulation predictor kits turn positive
• Progesterone rises, so a mid-luteal progesterone test reads as ovulatory
• Basal body temperature shifts, because that shift is driven by progesterone
• The period arrives roughly on schedule
• Cycle length and bleeding pattern look entirely normal

Everything that is normally used as proof of ovulation is measuring luteinization, not egg release. In LUF those two come apart.

LUF is not rare, and it is much more common in the population being investigated for infertility than in the general population.

In a study of 167 women with unexplained infertility undergoing IUI, published in Human Reproduction in 2006:

• 25% had LUF in their first monitored cycle
• Among those who returned for a second cycle, LUF recurred in 78.6%
• By the third cycle, the recurrence rate was 90%
• No pregnancies were recorded in any cycle affected by LUF

The recurrence figures are the clinically important part. A single anovulatory cycle is normal and happens to most people occasionally. LUF behaves differently — once it has occurred, it is likely to occur again in the following cycles.

That changes what the finding means. It is not bad luck in one month; it is a pattern that will probably repeat unless something changes. The authors concluded that other treatment options might be justified in these patients rather than continuing with the same approach.

Estimates of how often LUF occurs vary considerably between studies, partly because diagnosis requires intensive monitoring that most cycles never receive, and partly because populations differ.

This is the practical heart of the problem, and it explains a lot of frustration in unexplained infertility.

Each common test measures something that still happens in LUF:

• Ovulation predictor kits detect the LH surge in urine. The surge occurs normally in LUF — it simply fails to produce rupture
• Mid-luteal progesterone confirms a corpus luteum is producing progesterone. The luteinized follicle does exactly that
• Basal body temperature rises in response to progesterone, so the biphasic pattern appears
• Cycle tracking apps infer ovulation from these same signals and will report a normal ovulatory cycle

So someone with recurrent LUF can track carefully for a year, see textbook-perfect cycles every month, time intercourse precisely, and never release an egg.

The only reliable way to detect it is to watch the follicle:

• Serial transvaginal ultrasound tracking a follicle as it grows
• Then scanning again after the expected time of ovulation
• A follicle that persists rather than collapsing, and often develops internal echoes as it luteinizes, is the finding

This means the diagnosis requires several scans in a single cycle, which is why it is typically only looked for when infertility is otherwise unexplained.

This is the most actionable thing on this page, and it is frequently missed.

Non-steroidal anti-inflammatory drugs interfere with follicular rupture. Rupture depends on prostaglandins, and NSAIDs block prostaglandin synthesis.

A study of women with inflammatory arthropathies, published in Arthritis Care and Research in 2011, monitored cycles by ultrasound:

• LUF occurred in 35.6% of cycles with continuous NSAID exposure, against 3.4% in women not taking NSAIDs
• Etoricoxib, a COX-2 selective inhibitor, accounted for 75% of the LUF cases in continuously exposed patients
• Diclofenac accounted for 15%
• Ibuprofen at 1,600 mg per day did not induce LUF, either with continuous or intermittent exposure around ovulation

The authors concluded that continuous exposure to NSAIDs around ovulation should be avoided when planning a pregnancy.

Two points of nuance before acting on this:

• The pattern that mattered was continuous use around the time of ovulation, not an occasional tablet
• COX-2 selective drugs appeared considerably more potent at inducing LUF than non-selective ones

If you take NSAIDs regularly for arthritis, back pain, endometriosis pain or migraine, this is worth raising with your doctor. Do not stop a prescribed medication on your own — for many conditions there are alternatives that can be used around the fertile window instead.

Treatment is less well established than the diagnosis, and the studies are mostly small. The approaches used:

• Removing an identifiable cause, most obviously periovulatory NSAID use
• An hCG trigger injection timed to follicular maturity, to force rupture. This is the most widely used approach and mirrors what is done in IUI and IVF cycles anyway
• Adjusting the ovulation induction agent, since the drug used may influence LUF rates
• Moving to IVF, where eggs are retrieved directly from the follicles and rupture is bypassed entirely

The last option is worth stating plainly, because it is the one that removes the problem rather than treating it. In IVF the egg is aspirated from the follicle, so whether the follicle would have ruptured on its own becomes irrelevant.

Given the recurrence rates, repeating unmonitored natural or IUI cycles after a confirmed LUF is unlikely to be productive without a change of approach.

LUF also has implications for natural-cycle frozen embryo transfer, where transfer timing is set from the presumed ovulation. If the follicle has not ruptured, that timing is being calculated from an event that did not happen.

LUF is not part of a standard fertility workup, and for most people it does not need to be.

It becomes worth considering when:

• Infertility is unexplained after a normal workup — normal semen analysis, patent tubes, apparently normal ovulation
• Several well-timed cycles, including IUI cycles, have failed without explanation
• You take NSAIDs regularly, particularly COX-2 selective ones
• You have an inflammatory condition such as rheumatoid arthritis or endometriosis that is treated with regular NSAIDs

What to ask for is follicular tracking: serial transvaginal scans through the periovulatory window, including at least one after the expected day of ovulation. A single scan will not answer the question, because the finding is the absence of change over time.

If cycles are irregular, or ovulation is not occurring at all, that is a different problem with a different workup. LUF specifically describes cycles that look ovulatory but are not.

LUF is often confused with several other conditions that produce superficially similar situations. The distinctions matter because the treatments differ.

• Anovulation — no follicle matures and no LH surge occurs. Progesterone stays low and cycles are usually irregular. In LUF the follicle matures fully and progesterone rises
• PCOS — follicles stall at an immature stage and often no dominant follicle develops. LUF involves a fully mature follicle that fails at the final step
• Empty follicle syndrome — a phenomenon of IVF, where no eggs are retrieved despite apparently normal follicles at aspiration. Different context, different mechanism
• Luteal phase deficiency — the corpus luteum forms after normal ovulation but produces inadequate progesterone. The egg was released; the support afterwards is the issue
• Premature luteinization — progesterone rises too early, before the follicle is ready, typically noticed during stimulated cycles

The defining feature of LUF is the combination that makes it so easy to miss: a fully mature follicle, a normal LH surge, normal progesterone, a normal-looking cycle — and no egg release.

It is also worth saying that an occasional LUF cycle is thought to occur in women without fertility problems. It is the recurrence, and the association with otherwise unexplained infertility, that makes it clinically significant.

There is a specific context where LUF causes problems beyond natural conception: natural-cycle frozen embryo transfer.

In a natural-cycle FET, transfer timing is calculated from ovulation. The endometrium has to be at the right stage of the window of implantation when the embryo is placed, and that window is dated from the moment of ovulation.

If the follicle never ruptured:

• The presumed date of ovulation did not occur as assumed
• Progesterone still rises from the luteinized follicle, so the usual confirmation looks normal
• Endometrial development may be out of step with the calculated timing

This is one reason some clinics monitor follicular collapse by ultrasound in natural-cycle FET rather than relying on LH kits and progesterone alone, and one reason medicated cycles are sometimes preferred where LUF has been documented.

If you are having a natural-cycle transfer and LUF has been identified in the past, it is a reasonable thing to raise when the cycle is being planned rather than afterwards.

• Fertility Tests for Women: What Each One Checks, and When
• IUI vs IVF — Which Treatment Is Right for You? (2026)
• AMH Explained — What Your Result Means, and What It Does Not (2026)
• Follicular Study: What It Reveals
• Luteal Phase Defect: Diagnosis and Treatment
• Is Spotting a Sign of Ovulation?
• GnRH Antagonist vs Agonist Protocol — Which IVF Protocol, and Why (2026)